| Pharmacogenetics of CYP2C19: functional and clinical implications of a new variant CYP2C19* 17 A Li‐Wan‐Po, T Girard, P Farndon, C Cooley, J Lithgow British journal of clinical pharmacology 69 (3), 222-230, 2010 | 314 | 2010 |
| What to do with healthcare incident reporting systems JC Pham, T Girard, PJ Pronovost Journal of public health research 2 (3), jphr. 2013. e27, 2013 | 250 | 2013 |
| European Malignant Hyperthermia Group guidelines for investigation of malignant hyperthermia susceptibility PM Hopkins, H Rüffert, MM Snoeck, T Girard, KPE Glahn, FR Ellis, ... BJA: British Journal of Anaesthesia 115 (4), 531-539, 2015 | 197 | 2015 |
| Heart rate variability and cardiac troponin I are incremental and independent predictors of one-year all-cause mortality after major noncardiac surgery in patients at risk of … M Filipovic, R Jeger, C Probst, T Girard, M Pfisterer, L Gürke, K Skarvan, ... Journal of the American College of Cardiology 42 (10), 1767-1776, 2003 | 171 | 2003 |
| Junctate is a key element in calcium entry induced by activation of InsP3 receptors and/or calcium store depletion S Treves, C Franzini-Armstrong, L Moccagatta, C Arnoult, C Grasso, ... The Journal of cell biology 166 (4), 537-548, 2004 | 149 | 2004 |
| Effect of ryanodine receptor mutations on interleukin-6 release and intracellular calcium homeostasis in human myotubes from malignant hyperthermia-susceptible individuals and … S Ducreux, F Zorzato, C Muller, C Sewry, F Muntoni, R Quinlivan, ... Journal of Biological Chemistry 279 (42), 43838-43846, 2004 | 127 | 2004 |
| Recent advances in the diagnosis of malignant hyperthermia susceptibility: how confident can we be of genetic testing? RL Robinson, MJ Anetseder, V Brancadoro, C Van Broekhoven, ... European Journal of Human Genetics 11 (4), 342-348, 2003 | 118 | 2003 |
| B-lymphocytes from malignant hyperthermia-susceptible patients have an increased sensitivity to skeletal muscle ryanodine receptor activators T Girard, D Cavagna, E Padovan, G Spagnoli, A Urwyler, F Zorzato, ... Journal of Biological Chemistry 276 (51), 48077-48082, 2001 | 111 | 2001 |
| The myotonias and susceptibility to malignant hyperthermia J Parness, O Bandschapp, T Girard Anesthesia & Analgesia 109 (4), 1054-1064, 2009 | 110 | 2009 |
| Core myopathies and risk of malignant hyperthermia W Klingler, H Rueffert, F Lehmann-Horn, T Girard, PM Hopkins Anesthesia & Analgesia 109 (4), 1167-1173, 2009 | 108 | 2009 |
| Molecular genetic testing for malignant hyperthermia susceptibility T Girard, S Treves, E Voronkov, M Siegemund, A Urwyler The Journal of the American Society of Anesthesiologists 100 (5), 1076-1080, 2004 | 107 | 2004 |
| Malignant hyperthermia 2020: Guideline from the Association of Anaesthetists PM Hopkins, T Girard, S Dalay, B Jenkins, A Thacker, M Patteril, ... Anaesthesia 76 (5), 655-664, 2021 | 102 | 2021 |
| Adherence to the WHO surgical safety checklist: an observational study in a Swiss academic center R Schwendimann, C Blatter, M Lüthy, G Mohr, T Girard, S Batzer, E Davis, ... Patient safety in surgery 13, 1-6, 2019 | 96 | 2019 |
| Patient blood management (PBM) in pregnancy and childbirth: literature review and expert opinion D Surbek, Y Vial, T Girard, C Breymann, GA Bencaiova, D Baud, ... Archives of gynecology and obstetrics 301, 627-641, 2020 | 95 | 2020 |
| Functional and genetic characterization of clinical malignant hyperthermia crises: a multi-centre study W Klingler, S Heiderich, T Girard, E Gravino, JJA Heffron, S Johannsen, ... Orphanet journal of rare diseases 9, 1-15, 2014 | 84 | 2014 |
| Increasing the number of diagnostic mutations in malignant hyperthermia S Levano, M Vukcevic, M Singer, A Matter, S Treves, A Urwyler, T Girard Human mutation 30 (4), 590-598, 2009 | 80 | 2009 |
| New approaches to obstetric hemorrhage: the postpartum hemorrhage consensus algorithm T Girard, M Mörtl, D Schlembach Current Opinion in Anesthesiology 27 (3), 267-274, 2014 | 77 | 2014 |
| Must we press on until a young mother dies? Remifentanil patient controlled analgesia in labour may not be suited as a “poor man’s epidural” P Kranke, T Girard, P Lavand’homme, A Melber, J Jokinen, ... BMC pregnancy and childbirth 13, 1-8, 2013 | 75 | 2013 |
| Genotype‐phenotype comparison of the Swiss malignant hyperthermia population T Girard, A Urwyler, K Censier, CR Mueller, F Zorzato, S Treves Human mutation 18 (4), 357-358, 2001 | 73 | 2001 |
| Genotyping the butyrylcholinesterase in patients with prolonged neuromuscular block after succinylcholine S Levano, H Ginz, M Siegemund, M Filipovic, E Voronkov, A Urwyler, ... The Journal of the American Society of Anesthesiologists 102 (3), 531-535, 2005 | 72 | 2005 |
